David Cowley Zonies, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 647 Scenic Dr, Bernville, PA 19506 Phone: 610-926-3360 |
News Archive
Supplemental oxygen eliminates the rise in morning blood pressure experienced by obstructive sleep apnea patients who stop using continuous positive airway pressure, the standard treatment for OSA, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Keryx Biopharmaceuticals today announced completion of patient enrollment in the long-term study component of its Phase 3 registration program of Zerenex, the Company's ferric iron-based phosphate binder for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with end-stage renal disease (ESRD) on dialysis.
Mordor Intelligence releases their report on the Global Pharmaceutical Contract Manufacturing market is segmented by Dose Formulation type (Solid Dose Formulation, Liquid Dose Formulation, Injectable Dose Formulation - By Geographical Region (North America, Europe, Latin America, APAC, Middle East & Africa) - Drivers, Restraints, Vendor Profiles, Global Market Size, Forecasts & Analysis (2015-2020).
Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration recommended the approval of the investigational therapy Praluent (alirocumab) Injection.
› Verified 3 days ago